Elo Mutual Pension Insurance Co Sells 1,005 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Elo Mutual Pension Insurance Co trimmed its stake in HCA Healthcare, Inc. (NYSE:HCA) by 5.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 17,663 shares of the company’s stock after selling 1,005 shares during the quarter. Elo Mutual Pension Insurance Co’s holdings in HCA Healthcare were worth $5,302,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in HCA. WINTON GROUP Ltd bought a new position in shares of HCA Healthcare in the 4th quarter valued at about $270,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its position in HCA Healthcare by 6.8% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 294,597 shares of the company’s stock worth $87,407,000 after buying an additional 18,672 shares during the last quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund acquired a new stake in shares of HCA Healthcare in the fourth quarter valued at approximately $840,000. Woodmont Investment Counsel LLC raised its stake in HCA Healthcare by 3.8% in the 4th quarter. Woodmont Investment Counsel LLC now owns 58,724 shares of the company’s stock valued at $17,626,000 after acquiring an additional 2,168 shares during the period. Finally, Congress Wealth Management LLC DE boosted its position in HCA Healthcare by 3.4% during the fourth quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company’s stock worth $312,000 after purchasing an additional 34 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Trading Up 1.4 %

HCA opened at $341.94 on Friday. The company has a market cap of $84.19 billion, a P/E ratio of 15.56, a PEG ratio of 1.10 and a beta of 1.68. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The company’s 50 day moving average is $323.90 and its 200-day moving average is $341.86. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the previous year, the business posted $5.90 earnings per share. Equities research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be given a dividend of $0.72 per share. The ex-dividend date is Monday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a yield of 0.84%. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.11%.

Insider Buying and Selling at HCA Healthcare

In other news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 1.30% of the company’s stock.

Analyst Ratings Changes

HCA has been the subject of several research analyst reports. Truist Financial reduced their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a report on Monday, January 6th. Cantor Fitzgerald reiterated an “overweight” rating and set a $405.00 target price on shares of HCA Healthcare in a research note on Monday, January 27th. Morgan Stanley decreased their price objective on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 17th. KeyCorp decreased their price target on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. Finally, Royal Bank of Canada cut their price objective on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $385.67.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.